Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT01775748Not ApplicableCompleted

Effect of Concord Grape Juice on Endothelial Function

Role: collaborator

NCT01411631Not ApplicableCompleted

A Study to Investigate the Effect of Concord Grape Juice on Cognitive Function in Mums of Preteen Children

Role: collaborator

NCT00551746Not ApplicableCompleted

The Purple Grape Juice Study

Role: collaborator

NCT00302809Not ApplicableCompleted

Blood Pressure Lowering Effects of Grape Juice

Role: collaborator

All 4 trials loaded